Acromegaly surgery

Jump to navigation Jump to search

Acromegaly Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acromegaly from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Radiation Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acromegaly surgery On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acromegaly surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acromegaly surgery

CDC on Acromegaly surgery

Acromegaly surgery in the news

Blogs on Acromegaly surgery

Directions to Hospitals Treating Acromegaly

Risk calculators and risk factors for Acromegaly surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]

Overview

Surgery is the mainstay of treatment for acromegaly due to pituitary adenoma. The goal of the surgery will be the removal of the pituitary mass that causes acromegaly. The best sugical technique is endonasal transsphenoidal surgery.

Surgery

  • Surgery is the mainstay of treatment for acromegaly due to pituitary adenoma. The goal of the surgery will be the removal of the pituitary mass that causes acromegaly. The best sugical technique is endonasal transsphenoidal surgery.[1][2]

Endonasal transsphenoidal surgery

Most of the patients with acromegaly due to pituitary adenoma undergo transsphenoidal surgery. Although it is a challenging operation due to the anatomical location of the pituitary gland, tthe rate of complete successful resection in patients with adenomas smaller than 10 cm and GH level below 40ng is very high. It is important to remove the pituitary masses for this reasons:

MRI and CT imaging are used in guidance during the surgery and they have been linked with high safety and effectiveness of the surgery.[3]

In case the surgery is performed successfully, the acral features of acromegaly will improve within days.

Although it is very rare, some complications may occur. These complications include the following:[4][5]

Postoperatively, somatostatin analogs and radiotherapy are recommended in case of remaining excess of growth hormone.

Indicators of successful surgery:[6]

  • GH level falls to the normal level within few hours.
  • IGF-1 falls to the normal level within few days.

A video showing the procedure of endonasal transsphenoidal surgery:{{#ev:youtube|v=xllKSOXDuNM|}}

References

  1. Fahlbusch R, Honegger J, Buchfelder M (1992). "Surgical management of acromegaly". Endocrinol Metab Clin North Am. 21 (3): 669–92. PMID 1521518.
  2. Katznelson L, Laws ER, Melmed S, Molitch ME, Murad MH, Utz A; et al. (2014). "Acromegaly: an endocrine society clinical practice guideline". J Clin Endocrinol Metab. 99 (11): 3933–51. doi:10.1210/jc.2014-2700. PMID 25356808.
  3. Lasio G, Ferroli P, Felisati G, Broggi G (2002). "Image-guided endoscopic transnasal removal of recurrent pituitary adenomas". Neurosurgery. 51 (1): 132–6, discussion 136-7. PMID 12182410.
  4. Melmed S (2009). "Acromegaly pathogenesis and treatment". J Clin Invest. 119 (11): 3189–202. doi:10.1172/JCI39375. PMC 2769196. PMID 19884662.
  5. Cappabianca P, Cavallo LM, Colao A, de Divitiis E (2002). "Surgical complications associated with the endoscopic endonasal transsphenoidal approach for pituitary adenomas". J Neurosurg. 97 (2): 293–8. doi:10.3171/jns.2002.97.2.0293. PMID 12186456.
  6. Feelders RA, Bidlingmaier M, Strasburger CJ, Janssen JA, Uitterlinden P, Hofland LJ; et al. (2005). "Postoperative evaluation of patients with acromegaly: clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor I, acid-labile subunit, and growth hormone-binding protein levels". J Clin Endocrinol Metab. 90 (12): 6480–9. doi:10.1210/jc.2005-0901. PMID 16159936.

Template:WH Template:WS